JP2010504351A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504351A5
JP2010504351A5 JP2009529369A JP2009529369A JP2010504351A5 JP 2010504351 A5 JP2010504351 A5 JP 2010504351A5 JP 2009529369 A JP2009529369 A JP 2009529369A JP 2009529369 A JP2009529369 A JP 2009529369A JP 2010504351 A5 JP2010504351 A5 JP 2010504351A5
Authority
JP
Japan
Prior art keywords
phenyl
benzazepine
carbonyl
spiro
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009529369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/078917 external-priority patent/WO2008036755A1/en
Publication of JP2010504351A publication Critical patent/JP2010504351A/ja
Publication of JP2010504351A5 publication Critical patent/JP2010504351A5/ja
Pending legal-status Critical Current

Links

JP2009529369A 2006-09-22 2007-09-19 バソプレッシン拮抗薬として使用されるスピロベンズアゼピン類 Pending JP2010504351A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82665406P 2006-09-22 2006-09-22
PCT/US2007/078917 WO2008036755A1 (en) 2006-09-22 2007-09-19 Spiro benzazepines used as vasopressin antagonists

Publications (2)

Publication Number Publication Date
JP2010504351A JP2010504351A (ja) 2010-02-12
JP2010504351A5 true JP2010504351A5 (enExample) 2010-12-02

Family

ID=39030853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529369A Pending JP2010504351A (ja) 2006-09-22 2007-09-19 バソプレッシン拮抗薬として使用されるスピロベンズアゼピン類

Country Status (14)

Country Link
US (1) US7825110B2 (enExample)
EP (1) EP2078022B1 (enExample)
JP (1) JP2010504351A (enExample)
CN (1) CN101541806A (enExample)
AT (1) ATE532786T1 (enExample)
AU (1) AU2007299818B2 (enExample)
CA (1) CA2665849A1 (enExample)
CY (1) CY1112270T1 (enExample)
DK (1) DK2078022T3 (enExample)
ES (1) ES2374582T3 (enExample)
PL (1) PL2078022T3 (enExample)
PT (1) PT2078022E (enExample)
SI (1) SI2078022T1 (enExample)
WO (1) WO2008036755A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6050238B2 (ja) * 2011-10-19 2016-12-21 興和株式会社 新規なスピロインドリン化合物、及びそれを含有する医薬
EA201790185A1 (ru) 2014-07-15 2017-07-31 Грюненталь Гмбх Замещенные азаспиро(4.5)декановые производные
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
EP3321271B1 (en) 2015-07-07 2024-05-29 Japan Tobacco Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
MX2019007542A (es) 2016-12-21 2019-11-18 Japan Tobacco Inc Proceso para la preparación de derivados de 7h-pirrolo [2, 3-d] pirimidina y sus intermedios sintéticos.
MY208313A (en) 2017-09-15 2025-04-30 Azevan Pharmaceuticals Inc Compositions and methods for treating brain injury
WO2019141575A1 (de) 2018-01-16 2019-07-25 Bayer Aktiengesellschaft Unterstützung bei der behandlung von herzinsuffizienz
EP4192957A4 (en) * 2020-08-07 2024-09-04 Casma Therapeutics, Inc. Trpml modulators
EP4253367A4 (en) * 2020-11-26 2024-10-23 Shanghai Jemincare Pharmaceuticals Co., Ltd. NOVEL BENZAZEPINESPIRO DERIVATIVE
CN112939864B (zh) * 2021-01-29 2022-05-06 中国医科大学 螺[苯并[c]氮杂-1,1’-环己基]-3-酮类化合物
EP4491699A1 (de) 2023-07-13 2025-01-15 Klueber Lubrication München GmbH & Co. KG Phthalimidverbindungen als basisöl für schmierstoffzusammensetzungen
WO2026002248A1 (zh) * 2024-06-28 2026-01-02 上海济煜医药科技股份有限公司 作为v2受体拮抗剂的苯并氮杂卓并环衍生物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617302A (en) 1984-10-15 1986-10-14 Eli Lilly And Company Inotropic agents
JP2905909B2 (ja) * 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
US5985869A (en) 1989-10-20 1999-11-16 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
WO1991005549A1 (en) 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
FR2708605A1 (fr) 1993-07-30 1995-02-10 Sanofi Sa Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US5849780A (en) 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
FR2686878B1 (fr) * 1992-01-30 1995-06-30 Sanofi Elf Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
US5686624A (en) 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5663431A (en) 1992-01-30 1997-09-02 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
JPH08502474A (ja) 1992-10-07 1996-03-19 メルク エンド カンパニー インコーポレーテッド トコリティックオキシトシンレセプターアンタゴニスト
US5512563A (en) 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US5464788A (en) 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5753648A (en) 1995-01-17 1998-05-19 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AUPP150098A0 (en) 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
HUP0301590A3 (en) * 2000-07-05 2005-01-28 Ortho Mcneil Pharm Inc Nonpeptide substituted spirobenzoazepines as vasopressin antagonists, pharmaceutical compositions containing them and their preparation
CA2432825A1 (en) * 2000-12-15 2002-06-20 Emory University Nonpeptide agonists and antagonists of vasopressin receptors
US7011898B2 (en) * 2003-03-21 2006-03-14 Air Products And Chemicals, Inc. Method of joining ITM materials using a partially or fully-transient liquid phase
EA200501829A1 (ru) * 2003-06-17 2006-06-30 Янссен Фармацевтика Н. В. Способ получения непептидных замещённых спиробензоазепиновых производных
ES2332724T3 (es) * 2003-06-17 2010-02-11 Janssen Pharmaceutica Nv Espirobenzoazepinas sustituidas.
JP2009523806A (ja) * 2006-01-20 2009-06-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ (4r)−1−[4−(2−クロロ−5−フルオロベンゾイル)アミノ−3−メトキシベンゾイル]−1,2,3,5−テトラヒドロ−スピロ[4h−1−ベンズアゼピン−4,1’−[2]シクロペンテン]−3’−カルボン酸の新規固体形態物

Similar Documents

Publication Publication Date Title
JP2010504352A5 (enExample)
JP4671123B2 (ja) 新規三環性複素環化合物
JP6511430B2 (ja) がんの治療のための化合物および組成物
DK2303895T3 (en) Thiazolyl AND OXAZOLYLISOQUINOLINONER AND methods of use thereof
KR101463653B1 (ko) 디아민 유도체의 제조 방법
JP2010509356A5 (enExample)
JP2010536761A5 (enExample)
JP2008513496A5 (enExample)
JP2008510783A5 (enExample)
JP2015510942A5 (enExample)
KR102487051B1 (ko) 아미노카보닐카바메이트 화합물
AU2016298962B2 (en) Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
JP6386527B2 (ja) カリウムイオンチャネル阻害剤としてのピロロピリダジン
EP2970179A1 (en) Phthalazines as potassium ion channel inhibitors
EP3324954A1 (en) Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
JP2008525513A5 (enExample)
JP2016516691A (ja) カリウムイオンチャネル阻害剤としてのイソキノリン
WO2016025359A1 (en) Processes for the preparation of a bace inhibitor
JP2009519988A5 (enExample)
JP2007536262A5 (enExample)
BRPI0719570A2 (pt) Quinazolinas substituídas
JP2007521272A5 (enExample)
US20160009719A1 (en) Pyrrolotriazines as potassium ion channel inhibitors
US10618892B2 (en) Processes for the preparation of a BACE inhibitor
WO2016027757A1 (ja) 新規2-アミノベンゾイル誘導体